Showing results (1611-1620 of 1,769) with videos related to

Sort By:
Pageof 177
Neuroscience|December 18, 2023
Urolithin B Attenuates Cerebral Ischemia-reperfusion Injury by Modulating Nrf2-regulated Anti-oxidation in RatsZhi-Wei Li, Hua Tang, Xin-Xin Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 20, 2012
[10-year changes and development of surgical treatment for breast cancer in China]Bao-ning Zhang, Bin Zhang, Zhong-hua Tang, et al.
Pacing and Clinical Electrophysiology : PACE|July 24, 2012
Consistency of the automatic algorithm in detecting complex fractionated electrograms using an electroanatomical navigation systemWen-Chin Tsai, Ji-Hung Wang, Yenn-Jiang Lin, et al.
Cancer Letters|March 28, 2019
PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathwayQiu-Xia Yang, Shan Zhong, Lin He, et al.
Malaria Journal|February 6, 2015
In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013Hui Liu, Heng-lin Yang, Lin-hua Tang, et al.
Biomaterials Advances|May 30, 2026
An Abraxane-based albumin nanoplatform loaded with a STING agonist for synergistic dual immunotherapy of triple-negative breast cancerZhen Cao, Xiao-Jie Wei, Luan-Feng Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidizationO Jameel Shah, Xiaoyu Lin, Leiming Li, et al.
Gland Surgery|February 26, 2021
Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective studyWei Zhang, Bai-Lin Zhang, Jian-Jun He, et al.
BMC Cancer|August 24, 2011
A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in ChinaJing Li, Bao-Ning Zhang, Jin-Hu Fan, et al.
Journal of Hepatology|May 8, 2016
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1αFu-Quan Wu, Tian Fang, Le-Xing Yu, et al.
Pageof 177